Literature DB >> 3391639

Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation.

N Yousaf1, J C Howard, B D Williams.   

Abstract

The function of the hepatic component of the mononuclear phagocyte system (MPS) was investigated in the rat using N-ethylmaleimide (NEM)-treated erythrocytes and erythrocytes sensitized with a rat IgG2a monoclonal antibody (R2/15S) directed against the rat RT1Aa class I antigen. The clearance of the antibody-sensitized erythrocytes was biphasic, with the initial phase being rapid and complement dependent. This clearance was entirely hepatic and could be reduced or prevented by the infusion of cobra venom factor (CVF), complement fragments or small amounts of immune complexes, prepared either at equivalence or 10-fold antigen excess. NEM-treated cells were removed rapidly from the circulation of normal rats (t 1/2 6.2 +/- 0.4 min) and their clearance rate was not influenced by complement depletion. Most of the cells accumulated in the liver, although a small proportion (17%) was removed by the spleen. Immune complexes formed at equivalence or heat-aggregated human gamma globulin (HAGG) delayed the removal of these cells from the circulation, although significantly larger amounts of HAGG were required to do this. Antigen-excess immune complexes had no effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391639      PMCID: PMC1384942     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen. Synergy and interference in complement-mediated lysis.

Authors:  C I Bindon; G Hale; M Clark; H Waldmann
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

2.  Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways.

Authors:  C I Bindon; G Hale; N Hughes-Jones; B Gorick; H Waldmann
Journal:  Mol Immunol       Date:  1987-06       Impact factor: 4.407

3.  Immunosuppression in murine malaria. II. The effect on reticulo-endothelial and germinal centre function.

Authors:  B M Greenwood; J C Brown; D G De Jesus; E J Holborow
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

4.  In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.

Authors:  R P Taylor; G Kujala; K Wilson; E Wright; A Harbin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

5.  Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

6.  The FcR-mediated endocytosis of model immune complexes by cells from the P388D1 mouse macrophage line. II. The role of ligand-induced self-aggregation in promoting internalization.

Authors:  D M Segal; J A Titus; S K Dower
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Lack of binding of human C3, in its native state, to C3b receptors.

Authors:  M Berger; T A Gaither; C H Hammer; M M Frank
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Fc- and complement receptor-dependent degradation of soluble immune complexes and stable immunoglobulin aggregates by guinea pig monocytes, peritoneal macrophages, and Kupffer cells.

Authors:  M R Daha; L A van Es
Journal:  J Leukoc Biol       Date:  1984-11       Impact factor: 4.962

9.  NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases.

Authors:  M M Frank; T J Lawley; M I Hamburger; E J Brown
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

10.  Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.

Authors:  A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

View more
  6 in total

1.  Demonstration of hepatic Fc receptor function in vivo.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Effects of mannose and mannose derivatives on the clearance of IgG antibody-coated erythrocytes in the rat.

Authors:  M G Malaise; C Hoyoux; P Franchimont; J B Foidart; P R Mahieu
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

3.  The effect of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat.

Authors:  J P Camilleri; A S Williams; N Amos; A G Douglas-Jones; W G Love; B D Williams
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

4.  Systemic lupus erythematosus presenting as pneumococcal septicaemia and septic arthritis.

Authors:  J Webster; B D Williams; A P Smith; M Hall; J D Jessop
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

5.  Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.

Authors:  A S Williams; J P Camilleri; N Amos; B D Williams
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate.

Authors:  J P Camilleri; A S Williams; N Amos; A G Douglas-Jones; W G Love; B D Williams
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.